Assignee profile:

CELTAXSYS, INC.

City:

Atlanta, Georgia

Country:

United States

Published Applications:

17

Last publication date:

2018-06-14

Patent Grants:

15

Last grant date:

2019-12-10

Top Inventors for applications by CELTAXSYS, INC.

These are the the leading inventors for applications assigned to CELTAXSYS, INC.:

Recent patent applications by CELTAXSYS, INC.

CELTAXSYS, INC. based in Atlanta, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-06-14 ✅ Patent 10,501,455 granted on 2019-12-10
US20180162854A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#2 | 2018-06-14 ✅ Patent 10,202,362 granted on 2019-02-12
US20180162836A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#3 | 2018-06-14 ✅ Patent 10,202,334 granted on 2019-02-12
US20180162804A1
Chemistry; metallurgy

Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase

#4 | 2018-06-14 ✅ Patent 10,385,007 granted on 2019-08-20
US20180162802A1
Chemistry; metallurgy

Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase

#5 | 2018-05-10 ✅ Patent 10,399,986 granted on 2019-09-03
US20180127424A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#6 | 2018-05-03 ✅ Patent 10,350,197 granted on 2019-07-16
US20180117014A1
Human necessities

Methods of inhibiting leukotriene A4 hydrolase

#7 | 2016-03-10 ✅ Patent 9,777,006 granted on 2017-10-03
US20160068534A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#8 | 2016-03-10 ✅ Patent 9,856,249 granted on 2018-01-02
US20160068524A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#9 | 2016-03-10 ✅ Patent 9,822,106 granted on 2017-11-21
US20160068522A1
Chemistry; metallurgy

Inhibitors of leukotriene A4 hydrolase

#10 | 2016-03-10 ✅ Patent 9,820,974 granted on 2017-11-21
US20160067226A1
Human necessities

Methods of inhibiting leukotriene A4 hydrolase

#11 | 2015-03-19 ✅ Patent 9,315,509 granted on 2016-04-19
US20150080382A1
Chemistry; metallurgy

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#12 | 2014-10-02
US20140294862A1
Human necessities

METHODS OF MODULATING THE NEGATIVE CHEMOTAXIS OF IMMUNE CELLS

#13 | 2014-01-30
US20140031321A1
Human necessities

METHOD OF INDUCING NEGATIVE CHEMOTAXIS

#14 | 2010-08-19 ✅ Patent 8,569,303 granted on 2013-10-29
US20100210630A1
Chemistry; metallurgy

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#15 | 2010-08-12 ✅ Patent 9,617,330 granted on 2017-04-11
US20100203087A1
Chemistry; metallurgy

Chemorepulsion of cells

#16 | 2010-04-29 ✅ Patent 8,715,654 granted on 2014-05-06
US20100104587A1
Human necessities

Methods of modulating the negative chemotaxis of immune cells

#17 | 2010-04-15 ✅ Patent 8,377,914 granted on 2013-02-19
US20100093677A1
Human necessities

Method of inducing negative chemotaxis

Also check out Celtaxsys, Inc.'s (Atlanta, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

53455 ⎘